Dian Diagnostics Group Co.,Ltd. (300244.SZ)
CNY 14.03
(1.08%)
CNY 14.03
(1.08%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.31 Billion CNY | -27.49% |
| 2022 | 1.81 Billion CNY | -16.62% |
| 2021 | 2.18 Billion CNY | 8.33% |
| 2020 | 2.01 Billion CNY | -2.56% |
| 2019 | 2.06 Billion CNY | 8.93% |
| 2018 | 1.89 Billion CNY | -20.28% |
| 2017 | 2.37 Billion CNY | 97.03% |
| 2016 | 1.2 Billion CNY | 187.41% |
| 2015 | 420.05 Million CNY | 336.52% |
| 2014 | -177.59 Million CNY | 26.64% |
| 2013 | -242.09 Million CNY | 12.54% |
| 2012 | -276.82 Million CNY | 18.77% |
| 2011 | -340.78 Million CNY | -393.89% |
| 2010 | -68.99 Million CNY | -150.21% |
| 2009 | -27.57 Million CNY | -199.96% |
| 2008 | 27.58 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 2.39 Billion CNY | 10.88% |
| 2024 Q3 | 1.45 Billion CNY | -29.51% |
| 2024 Q1 | 2.15 Billion CNY | 63.81% |
| 2023 FY | 1.31 Billion CNY | -27.49% |
| 2023 Q4 | 1.31 Billion CNY | -37.16% |
| 2023 Q1 | 2.19 Billion CNY | 20.58% |
| 2023 Q3 | 2.09 Billion CNY | 2.17% |
| 2023 Q2 | 2.05 Billion CNY | -6.33% |
| 2022 Q3 | 2.94 Billion CNY | -10.58% |
| 2022 Q1 | 3.42 Billion CNY | 57.27% |
| 2022 FY | 1.81 Billion CNY | -16.62% |
| 2022 Q4 | 1.81 Billion CNY | -38.27% |
| 2022 Q2 | 3.29 Billion CNY | -3.96% |
| 2021 Q3 | 2.51 Billion CNY | -5.87% |
| 2021 Q1 | 2.55 Billion CNY | 26.91% |
| 2021 FY | 2.18 Billion CNY | 8.33% |
| 2021 Q4 | 2.18 Billion CNY | -13.35% |
| 2021 Q2 | 2.67 Billion CNY | 4.66% |
| 2020 Q2 | 2.62 Billion CNY | 2.98% |
| 2020 Q1 | 2.54 Billion CNY | 23.43% |
| 2020 FY | 2.01 Billion CNY | -2.56% |
| 2020 Q3 | 2.46 Billion CNY | -5.96% |
| 2020 Q4 | 2.01 Billion CNY | -18.48% |
| 2019 Q1 | 2.36 Billion CNY | 24.94% |
| 2019 FY | 2.06 Billion CNY | 8.93% |
| 2019 Q2 | 2.41 Billion CNY | 2.06% |
| 2019 Q3 | 2.4 Billion CNY | -0.41% |
| 2019 Q4 | 2.06 Billion CNY | -14.23% |
| 2018 Q3 | 3.19 Billion CNY | 5.94% |
| 2018 Q2 | 3.01 Billion CNY | 3.74% |
| 2018 Q1 | 2.9 Billion CNY | 22.31% |
| 2018 FY | 1.89 Billion CNY | -20.28% |
| 2018 Q4 | 1.89 Billion CNY | -40.69% |
| 2017 FY | 2.37 Billion CNY | 97.03% |
| 2017 Q2 | 2.05 Billion CNY | 4.36% |
| 2017 Q3 | 2.62 Billion CNY | 27.25% |
| 2017 Q1 | 1.97 Billion CNY | 63.46% |
| 2017 Q4 | 2.37 Billion CNY | -9.23% |
| 2016 Q3 | 659.61 Million CNY | 121.26% |
| 2016 Q1 | 2.37 Million CNY | -99.43% |
| 2016 FY | 1.2 Billion CNY | 187.41% |
| 2016 Q4 | 1.2 Billion CNY | 83.03% |
| 2016 Q2 | 298.12 Million CNY | 12426.4% |
| 2015 Q2 | 95.94 Million CNY | -43.64% |
| 2015 Q1 | 170.22 Million CNY | 195.85% |
| 2015 Q3 | 401.11 Million CNY | 318.08% |
| 2015 Q4 | 420.05 Million CNY | 4.72% |
| 2015 FY | 420.05 Million CNY | 336.52% |
| 2014 FY | -177.59 Million CNY | 26.64% |
| 2014 Q4 | -177.59 Million CNY | -20.79% |
| 2014 Q1 | -191.42 Million CNY | 20.93% |
| 2014 Q3 | -147.02 Million CNY | 33.47% |
| 2014 Q2 | -220.98 Million CNY | -15.44% |
| 2013 Q4 | -242.09 Million CNY | -11.07% |
| 2013 Q2 | -228.2 Million CNY | -0.57% |
| 2013 Q1 | -226.91 Million CNY | 18.03% |
| 2013 FY | -242.09 Million CNY | 12.54% |
| 2013 Q3 | -217.96 Million CNY | 4.49% |
| 2012 Q2 | -234.89 Million CNY | 9.84% |
| 2012 Q1 | -260.53 Million CNY | 23.55% |
| 2012 Q3 | -256.24 Million CNY | -9.09% |
| 2012 FY | -276.82 Million CNY | 18.77% |
| 2012 Q4 | -276.82 Million CNY | -8.03% |
| 2011 Q3 | -339.77 Million CNY | -514.95% |
| 2011 Q4 | -340.78 Million CNY | -0.3% |
| 2011 Q2 | -55.25 Million CNY | -0.37% |
| 2011 Q1 | -55.04 Million CNY | 20.22% |
| 2011 FY | -340.78 Million CNY | -393.89% |
| 2010 Q4 | -68.99 Million CNY | 0.0% |
| 2010 FY | -68.99 Million CNY | -150.21% |
| 2009 FY | -27.57 Million CNY | -199.96% |
| 2008 FY | 27.58 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Hangzhou Tigermed Consulting Co., Ltd. | -4.06 Billion CNY | 132.452% |
| Dirui Industrial Co.,Ltd. | -131.62 Million CNY | 1101.616% |
| Beijing Strong Biotechnologies, Inc. | 411.59 Million CNY | -220.303% |
| Medicalsystem Biotechnology Co., Ltd. | -850.71 Million CNY | 254.969% |
| Maccura Biotechnology Co.Ltd | -170.79 Million CNY | 871.896% |
| Guangzhou Wondfo Biotech Co.,Ltd | -240.75 Million CNY | 647.58% |
| Guangdong Hybribio Biotech Co.,Ltd. | -708.27 Million CNY | 286.133% |
| BGI Genomics Co., Ltd. | -3.63 Billion CNY | 136.258% |
| Amoy Diagnostics Co., Ltd. | -92.73 Million CNY | 1521.675% |
| Shanghai Labway Clinical Laboratory Co., Ltd. | -486.57 Million CNY | 370.941% |